Who Owns PMV Pharmaceuticals Stock?
NASDAQ: PMVPHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 46.43%
- Held by insiders
- 2.37%
- Institutional holders
- 79
- Institutions 46.4%
- Insiders 2.4%
- Public and other 51.2%
Who owns PMV Pharmaceuticals stock?
Institutional investors own about 46.4% of PMV Pharmaceuticals's shares, spread across 79 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 2.37% of PMVP.
The largest institutional holders are BML Capital Management, LLC (9.97%), Tang Capital Management, LLC (7.94%) and Sio Capital Management, LLC (4.93%). Together, the top 10 institutions control 50.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their PMVP positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PMVP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| BML Capital Management, LLC | 5.33M | 9.97% | +0.2% |
| Tang Capital Management, LLC | 4.25M | 7.94% | 0.0% |
| Sio Capital Management, LLC | 2.63M | 4.93% | -14.4% |
| Euclidean Capital Llc | 2.63M | 4.92% | 0.0% |
| Adage Capital Partners GP L.L.C. | 2.36M | 4.41% | +26.9% |
| Acadian Asset Management. LLC | 2.22M | 4.15% | 0.0% |
| Vanguard Capital Management LLC | 2.01M | 3.76% | +1.9% |
| ArrowMark Colorado Holdings LLC | 1.96M | 3.67% | -31.8% |
| Two Sigma Investments, LP | 1.95M | 3.66% | +3.7% |
| Eversept Partners, LP | 1.89M | 3.54% | -19.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PMVP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.49M | 2.78% |
| Meridian Fund Inc-Meridian Small Cap Growth Fund | 1.06M | 1.98% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 452.36K | 0.85% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 331.45K | 0.62% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 215.53K | 0.40% |
| iShares Trust-iShares Micro-Cap ETF | 159.47K | 0.30% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 74.05K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 71.19K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 59.92K | 0.11% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 45.05K | 0.08% |
Frequently asked questions
Who is the largest shareholder of PMV Pharmaceuticals?
BML Capital Management, LLC is the largest institutional shareholder of PMVP, owning 9.97% of shares outstanding (5.33M shares) as of its latest 13F filing.
What percentage of PMV Pharmaceuticals is owned by institutions?
Institutions own about 46.4% of PMVP shares and 47.6% of the public float.
How much of PMV Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 2.37% of PMVP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.